Champions Oncology, Inc.

NasdaqCM:CSBR 株式レポート

時価総額:US$54.4m

Champions Oncology 配当金

配当金 基準チェック /06

Champions Oncology does not have a record of paying a dividend.

主要情報

n/a

配当利回り

-0.4%

バイバック利回り

総株主利回り-0.4%
将来の配当利回りn/a
配当成長n/a
次回配当支払日n/a
配当落ち日n/a
一株当たり配当金n/a
配当性向n/a

最近の配当金アップデート

更新なし

Recent updates

Companies Like Champions Oncology (NASDAQ:CSBR) Can Afford To Invest In Growth

Oct 24
Companies Like Champions Oncology (NASDAQ:CSBR) Can Afford To Invest In Growth

It's A Story Of Risk Vs Reward With Champions Oncology, Inc. (NASDAQ:CSBR)

Jun 14
It's A Story Of Risk Vs Reward With Champions Oncology, Inc. (NASDAQ:CSBR)

Is Now The Time To Put Champions Oncology (NASDAQ:CSBR) On Your Watchlist?

Sep 28
Is Now The Time To Put Champions Oncology (NASDAQ:CSBR) On Your Watchlist?

Champions Oncology Non-GAAP EPS of -$0.02, revenue of $12.9M

Jul 21

We Think Some Shareholders May Hesitate To Increase Champions Oncology, Inc.'s (NASDAQ:CSBR) CEO Compensation

Oct 14
We Think Some Shareholders May Hesitate To Increase Champions Oncology, Inc.'s (NASDAQ:CSBR) CEO Compensation

We Think Champions Oncology (NASDAQ:CSBR) Can Afford To Drive Business Growth

Jun 21
We Think Champions Oncology (NASDAQ:CSBR) Can Afford To Drive Business Growth

Are Investors Undervaluing Champions Oncology, Inc. (NASDAQ:CSBR) By 44%?

Apr 09
Are Investors Undervaluing Champions Oncology, Inc. (NASDAQ:CSBR) By 44%?

Here's Why We're Not At All Concerned With Champions Oncology's (NASDAQ:CSBR) Cash Burn Situation

Mar 19
Here's Why We're Not At All Concerned With Champions Oncology's (NASDAQ:CSBR) Cash Burn Situation

The Champions Oncology (NASDAQ:CSBR) Share Price Has Gained 243%, So Why Not Pay It Some Attention?

Mar 02
The Champions Oncology (NASDAQ:CSBR) Share Price Has Gained 243%, So Why Not Pay It Some Attention?

Is There Now An Opportunity In Champions Oncology, Inc. (NASDAQ:CSBR)?

Feb 04
Is There Now An Opportunity In Champions Oncology, Inc. (NASDAQ:CSBR)?

Do Insiders Own Lots Of Shares In Champions Oncology, Inc. (NASDAQ:CSBR)?

Jan 14
Do Insiders Own Lots Of Shares In Champions Oncology, Inc. (NASDAQ:CSBR)?

Philip Breitfeld Is The Chief Strategy & Innovation Officer and Director of Champions Oncology, Inc. (NASDAQ:CSBR) And They Just Sold 100% Of Their Shares

Dec 19
Philip Breitfeld Is The Chief Strategy & Innovation Officer and Director of Champions Oncology, Inc. (NASDAQ:CSBR) And They Just Sold 100% Of Their Shares

Champions Oncology, Inc. (NASDAQ:CSBR) Analysts Are Pretty Bullish On The Stock After Recent Results

Dec 16
Champions Oncology, Inc. (NASDAQ:CSBR) Analysts Are Pretty Bullish On The Stock After Recent Results

Champions Oncology beats on revenue

Dec 14

Estimating The Fair Value Of Champions Oncology, Inc. (NASDAQ:CSBR)

Dec 04
Estimating The Fair Value Of Champions Oncology, Inc. (NASDAQ:CSBR)

決済の安定と成長

配当データの取得

安定した配当: Insufficient data to determine if CSBR's dividends per share have been stable in the past.

増加する配当: Insufficient data to determine if CSBR's dividend payments have been increasing.


配当利回り対市場

Champions Oncology 配当利回り対市場
CSBR 配当利回りは市場と比べてどうか?
セグメント配当利回り
会社 (CSBR)n/a
市場下位25% (US)1.5%
市場トップ25% (US)4.5%
業界平均 (Life Sciences)0.5%
アナリスト予想 (CSBR) (最長3年)n/a

注目すべき配当: Unable to evaluate CSBR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

高配当: Unable to evaluate CSBR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


株主への利益配当

収益カバレッジ: Insufficient data to calculate CSBR's payout ratio to determine if its dividend payments are covered by earnings.


株主配当金

キャッシュフローカバレッジ: Unable to calculate sustainability of dividends as CSBR has not reported any payouts.


高配当企業の発掘